Krystal Biotech Inc (NASDAQ:KRYS)
| 121.99 BATS BZX Real-Time Price As of 1:53pm ET |  -2.03 / -1.64%Today’s Change | 49.17 Today|||52-Week Range 126.45 | +53.99% Year-to-Date |
Latest KRYS News | Press Releases
| Up 48% in 2023, Is This Biotech Stock a Buy? Jun 03 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 124.02 |
| Today’s open | 124.00 |
| Day’s range | 120.52 - 126.45 |
| Volume | 6,052 |
| Average volume (3 months) | 242,411 |
| Market cap | $3.4B |
Data as of 1:53pm ET, 06/05/2023
Growth & Valuation
| Earnings growth (last year) | -75.20% |
| Earnings growth (this year) | +7.60% |
| Earnings growth (next 5 years) | -22.67% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 6.13 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| FOLDAmicus Therapeutics ... | +0.11 | +0.91% |
| RETAReata Pharmaceutical... | -1.68 | -1.80% |
| ---- | ||
| PTCTPTC Therapeutics Inc | -1.45 | -3.29% |
Data as of 1:53pm ET, 06/05/2023
Financials
| Next reporting date | August 7, 2023 |
| EPS forecast (this quarter) | -$1.31 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$140.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Pittsburgh, Pennsylvania |
Forecasts
